Kotloff, KL, et al.
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization
1999; 77: 651–666.
Voetsch, AC, et al.
Laboratory practices for stool-specimen culture for bacterial pathogens, including Escherichia coli O157:H7, in the FoodNet sites, 1995–2000. Clinical Infectious Diseases
2004; 38 (Suppl. 3): S190–197.
Bardhan, P, et al.
Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia. Emerging Infectious Diseases
2010; 16: 1718–1723.
Niyogi, SK. Shigellosis. Journal of Microbiology
2005; 43: 133–143.
Ahmed, F, et al.
Epidemiology of post-shigellosis persistent diarrhea in young children. Pediatric Infectious Disease Journal
2001; 20: 525–530.
Bennish, ML, Wojtyniak, BJ. Mortality due to shigellosis – community and hospital data. Reviews of Infectious Diseases
1991; 13: S245–S251.
Black, RE, et al.
Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens. American Journal of Epidemiology
1982; 115: 315–324.
Hyams, KC, et al.
Diarrheal disease during Operation Desert Shield. New England Journal of Medicine
1991; 325: 1423–1428.
DuPont, HL, et al.
Inoculum size in shigellosis and implications for expected mode of transmission. Journal of Infectious Diseases
1989; 159: 1126–1128.
Cohen, D, et al.
Reduction of transmission of shigellosis by control of houseflies (Musca domestica). Lancet
1991; 337: 993–997.
Green, MS, et al.
Four decades of shigellosis in Israel: epidemiology of a growing public health problem. Reviews of Infectious Diseases
1991; 13: 248–253.
Ostroi, P, Anis, E, Green, MS. Shigellosis in Israel – update 1995. Public Health Reviews
1996; 24: 213–225.
Israel Center for Diseases Control and Division of Epidemiology Public Health Services MoH. Notifiable infectious diseases in Israel. 60 years of surveillance 1951–2010. Tel Hashomer: Ministry of Health, 2012.
Bauer, AW, et al.
Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology
1966; 45: 493–496.
Standards NCfCL. Performance standards for antimicrobial susceptibility testing. NCCLS approved standard M100-S9, 1999.
Ziv, T, et al.
Assessment of the underestimation of childhood diarrhoeal disease burden in Israel. Epidemiology and Infection
2011; 139: 1379–1387.
Chompook, P, et al.
Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bulletin of the World Health Organization
2005; 83: 739–746.
von Seidlein, L, et al.
A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Medicine
2006; 3: e353.
Abramson, JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiologic Perspectives & Innovations
2011; 8: 1.
Egoz, N, et al.
An outbreak of Shigella sonnei infection due to contamination of a municipal water-supply in northern Israel. Journal of Infection
1991; 22: 87–93.
Gupta, A, et al.
Laboratory-confirmed shigellosis in the United States, 1989–2002: epidemiologic trends and patterns. Clinical Infectious Diseases
2004; 38: 1372–1377.
Lerman, Y, et al.
Epidemic spread of Shigella sonnei shigellosis and evidence for development of immunity among children attending day-care-centers in a communal settlement (kibbutz). Journal of Clinical Microbiology
1994; 32: 1092–1094.
Sack, DA, et al.
Is protection against shigellosis induced by natural infection with Plesiomonas shigelloides?
1994; 343: 1413–1415.
Vinh, H, et al.
A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation. BMC Infectious Diseases
2009; 9: 204.
Levine, MM, et al.
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nature Reviews Microbiology
2007; 5: 540–553.
Khan, MU. Interruption of shigellosis by hand washing. Transactions of the Royal Society of Tropical Medicine and Hygiene
1982; 76: 164–168.
Pickering, LK. The day care center diarrhea dilemma. American Journal of Public Health
1986; 76: 623–624.
Pickering, LK, et al.
Diarrhea caused by Shigella, rotavirus, and Giardia in day-care centers: prospective study. Journal of Pediatrics
1981; 99: 51–56.
Shane, AL, et al.
Sharing Shigella: risk factors for a multicommunity outbreak of shigellosis. Archives of Pediatrics & Adolescent Medicine
2003; 157: 601–603.
Mohle-Boetani, JC, et al.
Communitywide shigellosis: control of an outbreak and risk factors in child day-care centers. American Journal of Public Health
1995; 85: 812–816.
Garrett, V, et al.
A recurring outbreak of Shigella sonnei among traditionally observant Jewish children in New York City: the risks of daycare and household transmission. Epidemiology and Infection
2006; 134: 1231–1236.
Green, MS, et al.
The changing epidemiology of viral hepatitis A in Israel. Israel Medical Association Journal
2001; 3: 347–351.
Rosenberg, ML, et al.
Shigella surveillance in the United States, 1975. Journal of Infectious Diseases
1977; 136: 458–460.
Herrington, DA, et al.
Studies in volunteers to evaluate candidate Shigella vaccines – further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease. Vaccine
1990; 8: 353–357.
Ferreccio, C, et al.
Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile. American Journal of Epidemiology
1991; 134: 614–627.
Cohen, D, et al.
Serum antibodies to lipopolysaccharide and natural immunity to shigellosis in an Israeli military population. Journal of Infectious Diseases
1988; 157: 1068–1071.
Cohen, D, et al.
Prospective study of the association between serum antibodies to lipopolysaccharide O antigen and the attack rate of shigellosis. Journal of Clinical Microbiology
1991; 29: 386–389.
Mates, A, Eyny, D, Philo, S. Antimicrobial resistance trends in Shigella serogroups isolated in Israel, 1990–1995. European Journal of Clinical Microbiology
2000; 19: 108–111.
Vasilev, V, et al.
Antimicrobial resistance of Shigella flexneri serotypes in Israel during a period of three years: 2000–2002. Epidemiology and Infection
2004; 132: 1049–1054.
Vrints, M, et al.
Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. Journal of Clinical Microbiology
2009; 47: 1379–1385.
Shiferaw, B, et al.
Antimicrobial Susceptibility Patterns of Shigella Isolates in Foodborne Diseases Active Surveillance Network (FoodNet) Sites, 2000–2010. Clinical Infectious Diseases
2012; 54: S458–S463.
Wong, MR, et al.
Antimicrobial resistance trends of Shigella serotypes in New York City, 2006–2009. Microbial Drug Resistance
2010; 16: 155–161.
Kosek, M, et al.
Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon. Pediatrics
2008; 122: e541–549.
Banga, Singh KK, et al.
A 9-year study of shigellosis in Northeast Malaysia: Antimicrobial susceptibility and shifting species dominance. Zeitschrift fur Gesundheitswissenschaften
2011; 19: 231–236.